Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The aim of this study is to investigate the continued usage of standard diabetes medications in the post operative period following bariatric surgery to determine whether this approach may improve long term diabetes control. At present, the standard of treatment in patients with type 2 diabetes is that all medication is stopped in the immediate postoperative period and only re-started if symptoms of diabetes re-emerge. Although a large proportion of patients with diabetes will initially go in to remission, 80% experience relapse within five years. This study is needed to determine whether continuing medications is not only safe but will improve long term outcomes for patients with diabetes.
Sponsor: Imperial College London
You may qualify if…
- ✓ eligible for bariatric surgery according to NICE guidelines (GC 189)
- ✓ Type 2 diabetes mellitus
- ✓ BMI \>30kg/m2
You may not qualify if…
- ✕ Recent hospitalisation in the past 30 days
- ✕ Recurrent hypoglycaemic episodes
- ✕ Recurrent hypotensive episodes
- ✕ Contraindications to bariatric surgery
- ✕ Previous bariatric surgery
- ✕ Current pregnancy
- ✕ Breastfeeding
Source: ClinicalTrials.gov · NCT04432025 · last updated 2022-08-08